⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

May 14, 2024Diabetes TherapyOpen Access

Changes in Basal and Bolus Insulin Requirements with Tirzepatide as an Adjunctive Therapy in Adults with Type 1 Diabetes Using Tandem Control-IQ

Kagan E. Karakus Matthew P. Klein Halis Kaan Aktürk Viral N. Shah

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

This study was aimed at investigating changes in insulin requirements and glycemic outcomes in adults with type 1 diabetes (T1D) using Control IQ (Tandem Diabetes) automated insulin delivery system (AID) over 8 months of tirzepatide treatment.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Karakus et al. (2024) studied this question.

synapsesocial.com/papers/68e6a284b6db643587625e59 https://doi.org/10.1007/s13300-024-01592-9

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1748-P: Tirzepatide Adjunctive Therapy in Adults with Type 1 Diabetes Using Tandem Control-IQ2024
2Tirzepatide Is Associated With Improved Metabolic Outcomes in People With Type 1 Diabetes and Overweight or Obesity: A Retrospective Cohort StudyCohort Study · 2026 · 1 citations
3Glucose Control and Continuous Glucose Monitoring Metrics During 12 Months of Treatment with Tirzepatide in Overweight or Obese Patients with Type 1 Diabetes.cohort · 2026 · 3 citations
4802-P: A New Dawn beyond Basal Insulin? Dose-Response Meta-analysis for Efficacy and Safety of Tirzepatide Compared with Basal Insulin in Uncontrolled Diabetes Mellitus2024 · 1 citations
51705-P: Effects of Tirzepatide in Obese Adults with Type 1 Diabetes on Hybrid Closed-Loop Continuous Subcutaneous Insulin Infusion: A 12-Month Observational StudyObservational Study · 2026

Tirzepatide as Adjunct to Insulin in Adults With Type 1 Diabetes and Overweight or Obesity: A Systematic Review of Randomized and Real‐World Evidence2026
761-P: Use of Tirzepatide in Type 1 Diabetes2024
Tirzepatide for the treatment of adults living with concurrent type 1 diabetes and overweight or obesity (TZP-T1D): a double-blind, placebo-matched randomised controlled trial protocol2025
Reducing the Burden of Hypoglycemia in Type 1 Diabetes: The Impact of FLO23011 on Patient-Reported Outcomes and Glycemic Correlates of Treatment ResponseDiabetes Therapy · 2026
A Malaysian Expert Consensus on The Identification, Evaluation, and Pharmacological Management of Diabetic Sensorimotor PolyneuropathyDiabetes Therapy · 2026

More from Diabetes Therapy

More from University of Colorado Anschutz Medical Campus